Skip to content

MoonLake Immunotherapeutics MLTX Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax

Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax at other companies

First BanCorp logo
First BanCorpFBP
-$102.25K+35.6%
MoonLake Immunotherapeutics logo
MoonLake ImmunotherapeuticsMLTX
-$359K-478%
TFX
TeleflexTFX
$1.02M-60.1%
PBH
Prestige Consumer HealthcarePBH
-$24K-18.5%
CSX logo
CSXCSX
-$250K-102%
John Wiley & Sons, Inc. logo
John Wiley & Sons, Inc.WLYB
$6.48M+392%

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.56B-45.9%
Enterprise value$1.36B-50.0%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MoonLake Immunotherapeutics's other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax?
MoonLake Immunotherapeutics (MLTX) reported other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax of -$359K in Q1 2026.
How has MoonLake Immunotherapeutics's other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax changed year-over-year?
MoonLake Immunotherapeutics's other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax decreased by 477.9% year-over-year, from $95K to -$359K.
What does other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, after tax mean?
This metric represents the actuarial gains or losses arising from changes in the assumptions used to value the company's defined benefit pension or employee benefit obligations. These adjustments are recognized outside of net income to reflect changes in long-term liabilities due to factors like discount rates or demographic shifts. It is essential for understanding the long-term financial impact of employee benefit commitments.